Texas Health Presbyterian Hospital Kaufman
Texas Health Presbyterian Hospital Kaufman was paid $4.09M by Medicaid between Jan 2020 and Dec 2024, across 60 billing codes. Its largest line is 99284, emergency room visit (serious) — 41% of everything it billed.
KAUFMAN, TX 75142
Next to other Critical Access Hospital Clinic/Center providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 634 | $65K | |
| 2021 | 19,498 | $859K | |
| 2022 | 30,606 | $1.34M | |
| 2023 | 25,259 | $1.36M | |
| 2024incomplete | 9,687 | $474K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 41% | 7,838 | 7,491 | $1.67M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 10,790 | 10,472 | $654K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.7% | 1,277 | 1,177 | $357K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.0% | 3,786 | 3,722 | $287K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.9% | 642 | 587 | $158K |
| 71045 | Radiologic examination, chest; single view | 3.8% | 4,079 | 3,888 | $156K |
| 80053 | Comprehensive metabolic panel | 3.0% | 5,042 | 4,480 | $123K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 3,209 | 3,156 | $102K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 1,490 | 1,457 | $78K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 6,230 | 5,494 | $72K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 5,073 | 4,981 | $63K |
| 87430 | 1.3% | 3,315 | 3,268 | $54K |
48 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 1,833 | $50K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 482 | $35K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 722 | $32K |
| 81003 | <1% | 4,690 | $28K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 514 | $22K |
| 83690 | <1% | 2,374 | $22K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 291 | $14K |
| 87634 | <1% | 186 | $13K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,698 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 721 | $11K |
| 84484 | <1% | 1,547 | $10K | |
| 83880 | <1% | 559 | $10K | |
| 81025 | <1% | 881 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,113 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 86 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 228 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 865 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 970 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 35 | $4K |
| 83605 | <1% | 436 | $3K | |
| 84703 | <1% | 514 | $3K | |
| 87040 | <1% | 477 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 650 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 393 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 400 | $2K |
| 85730 | <1% | 512 | $2K | |
| 85610 | <1% | 568 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,596 | $1K |
| CP007 | <1% | 31 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 206 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $864.51 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 576 | $815.53 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 263 | $530.96 |
| 87081 | <1% | 25 | $380.15 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 262 | $317.92 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 118 | $261.87 |
| 81001 | <1% | 84 | $221.12 | |
| 96376 | <1% | 48 | $210.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 283 | $207.71 |
| 85379 | <1% | 32 | $159.87 | |
| 86900 | <1% | 63 | $107.06 | |
| 86901 | <1% | 56 | $97.46 | |
| 83735 | <1% | 16 | $75.32 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 68 | $73.27 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 156 | $31.05 |
| 94760 | <1% | 19 | $19.39 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,286 | $10.72 |
| A9270 | Non-covered item or service | 0% | 2,968 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Texas Health Harris Methodist Hospital Fort Worth | Fort Worth, TX | $13.83M |
| Texas Health Arlington Memorial Hospital | Arlington, TX | $8.23M |
| Texas Health Presbyterian Hospital Dallas | Dallas, TX | $5.33M |
| Texas Health Harris Methodist Hospital Southwest Fort Worth | Fort Worth, TX | $5.20M |
| Texas Health Presbyterian Hospital Denton | Denton, TX | $3.84M |
| Texas Health Harris Methodist Hospital Stephenville | Stephenville, TX | $3.69M |
| Texas Health Harris Methodist Hospital Hurst-Euless-Bedford | Bedford, TX | $3.57M |
| Texas Health Presbyterian Hospital Plano | Plano, TX | $2.32M |
| Texas Health Harris Methodist Hospital Cleburne | Cleburne, TX | $2.31M |
| Texas Health Harris Methodist Hospital Azle | Azle, TX | $2.14M |
| Texas Health Harris Methodist Hospital Alliance | Fort Worth, TX | $986K |
| Texas Health Presbyterian Hospital Allen | Allen, TX | $965K |
| Texas Health Hospital Frisco | Frisco, TX | $473K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.